Repeated BP Measures Linked to Drop in Initially Elevated BP

Share this content:
Repeated BP Measures Linked to Drop in Initially Elevated BP
Repeated BP Measures Linked to Drop in Initially Elevated BP

TUESDAY, April 17, 2018 (HealthDay News) -- Among patients with hypertension (HTN), repeated measurement of an initially elevated blood pressure (BP) is associated with a reduction in systolic BP, according to a research letter published online April 16 in JAMA Internal Medicine.

Douglas Einstadter, M.D., M.P.H., from Case Western Reserve University in Cleveland, and colleagues examined the effect of a second BP measurement on the rate of BP control among patients with diagnosed HTN. An advisory alert was introduced into the electronic health record to remind staff to remeasure BP when the initial reading was elevated (≥140/90 mm Hg). A total of 38,260 patients with HTN made 80,864 primary care office visits during the study period.

The researchers found that the initial BP was at least 140/90 mm Hg at 39 percent of the visits, and an initially elevated BP was remeasured in 83 percent of cases. The median change in systolic BP was −8 mm Hg. There was a positive correlation for change in systolic BP with initial BP value, with a greater change in the final BP the higher the initial systolic BP. Also, among all the patients with a repeated measurement, 36 percent of final readings were below 140/90 mm Hg.

"Implementing routine repeated measurement for an initially elevated BP may contribute to improved decision making around HTN management and should be considered a standard component of programs to improve BP control," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »